Association for Accessible Medicines
FDANonrulemakingFDA-2017-D-5974

Determining Whether to Submit an ANDA or a 505(b)(2) Application; Draft Guidance for Industry; Availability

RIN
Last modified
May 13, 2019
Comment window
closed 3088d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Dec 15, 2017 and Dec 15, 2017. 0 other organizations filed here. The comment window closed 3088d ago.

What Association for Accessible Medicines filed (1)

Dec 15, 2017· Comment from Association for Accessible Medicines· FDA-2017-D-5974-0007

Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies, regarding Docket FDA-2017-D-5974: Determining Whether to Submit an ANDA or a 505(b)(2) Application.

Abstract

No abstract recorded.

View on regulations.gov →